MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ndt/gft197

Медицинская библиотека · Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2013

How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipients.

Bray Benjamin D, Boyd Jennifer, Daly Conal, Doyle Arthur, Donaldson Ken, Fox Jonathan G, Innes Andrew, Khan Izhar, Mackinnon Bruce, Peel Robert K, Shilliday Ilona, Simpson Keith, Stewart Graham A, Traynor Jamie P, Metcalfe Wendy, Scottish Renal Registry (SRR)

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Patients receiving treatment with renal replacement therapy (RRT) have high mortality, and ensuring patient safety in this population is difficult. We aimed to estimate the incidence and nature of medical adverse events contributing to the death of patients being treated with RRT.

METHODS

This population registry-based retrospective case review study included all patients being treated with RRT for established renal failure in Scotland and who died between 1 January 2008 and 30 June 2011. Deaths were reviewed by consultant nephrologists using a structured questionnaire to identify factors contributing to death occurring in both the inpatient and outpatient setting. Reviewers were able to use any information source deemed relevant, including paper and electronic clinical records, mortality and morbidity meetings and procurator fiscal (Scottish coroner) investigations. Deaths occurring in 2008 and 2009 where avoidable factors were identified that may have or did lead to death of a patient were subject to further review and root cause analysis, in order to identify recurrent themes.

RESULTS

Of 1551 deaths in the study period, 1357 were reviewed (87.5%). Cumulative RRT exposure in the cohort was 2.78 million person-days. RRT complications were the primary cause of death in 28 (2.1%). Health-care-associated infection had contributed to 9.6% of all deaths. In 3.5% of deaths, factors were identified which may have or did contribute to death. These were both organizational and human error related and were largely due to five main causes: management of hyperkalaemia, prescribing, out of hours care, infection and haemodialysis vascular access.

CONCLUSIONS

Adverse events contributing to death in RRT recipients mainly relate to the everyday management of common medical problems and not the technical aspects of RRT. Efforts to avoid harm in this population should address these ubiquitous causes of harm.

Для цитирования: Bray Benjamin D, Boyd Jennifer, Daly Conal, Doyle Arthur, Donaldson Ken, Fox Jonathan G, Innes Andrew, Khan Izhar, Mackinnon Bruce, Peel Robert K, Shilliday Ilona, Simpson Keith, Stewart Graham A, Traynor Jamie P, Metcalfe Wendy, Scottish Renal Registry (SRR). How safe is renal replacement therapy? A national study of mortality and adverse events contributing to the death of renal replacement therapy recipients.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2013. DOI: 10.1093/ndt/gft197.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.